Seeking Alpha · ODTX · October 20, 2026

Odyssey Therapeutics, Inc. (ODTX) Discusses Additional Phase IIa Data for OD-001 in Ulcerative Colitis from UEG Week Presentation Transcript

Get the app for more

Explore stock news, insights and company research.